This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Amgen Inc., Amgen Research (Munich) Gmbh. Active years: 2025.
Company Filing History:
1 out of 2,069 
1 out of 77 
Years Active: 2025
Title: Claudia Bluemel: Innovator in Antibody Research
Introduction
Claudia Bluemel is a distinguished inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to advancements in therapeutic applications.
Latest Patents
Claudia Bluemel holds a patent for "Anti-CCR8 antibodies and uses thereof." This invention provides anti-CCR8 antibodies and antigen-binding fragments, along with methods for their production and application. The patent highlights the potential of these antibodies in various medical treatments.
Career Highlights
Throughout his career, Claudia has worked with notable companies, including Amgen Inc. and Amgen Research (Munich) GmbH. His experience in these organizations has allowed him to refine his expertise in antibody research and development.
Collaborations
Claudia has collaborated with talented individuals such as Nathan William Pierce and Agnieszka Kielczewska. These partnerships have contributed to the success of his projects and the advancement of scientific knowledge in his field.
Conclusion
Claudia Bluemel's work in antibody research exemplifies innovation and dedication to improving therapeutic options. His contributions continue to impact the biotechnology industry positively.